Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT02811250
Eligibility Criteria:
Inclusion Criteria:
* Patient aged over 75 years with an operable renal tumor or patient with inoperable renal tumor irrespective of age, or patient with metastatic renal tumor and indication for nephrectomy.
* Histologically-confirmed Renal carcinoma less than or equal to 4 cm
* Tumor that is visible and measureable on abdominal scanner and/or MRI (Magnetic Resonance Imaging)
* Karnofsky performance status ≥ 60%
Exclusion Criteria:
* Patient with only one kidney and renal cancer
* Patient not able to cooperate during treatment
* Previous history of abdominal radiation therapy
* Tumor having infiltrated the renal pelvis
* Polycystic kidney disease
* Previous history of intestinal inflammatory disease such as ulcerative colitis or Crohn's disease
* Renal insufficiency (creatinine clearance \<30 ml/mm evaluated by DTPA (diethylenetriamine pentaacetic acid ) scintigraphy)
* Uncontrolled hypertension (SBP(systolic blood pressure) above 160 mmHg DBP(diastolic blood pressure) above 100 mmHg with antihypertensive treatment)
* Non primary lesions (benign lesions such as angiomyolipoma, renal metastases,…)
* Antineoplastic and/or antiangiogenic treatment in the month preceding radiotherapy
* Progressive cancer other than renal cancer at time of inclusion with the exception of in situ cervical carcinomas, basal cell carcinoma of the skin, and non-metastatic prostate cancer controlled without hormone therapy
* Participation in another ongoing study that may interfere with the present study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
75 Years
Study:
NCT02811250
Study Brief:
Protocol Section:
NCT02811250